Clinical trial
Anti-CD20 Antibody Rituximab in Addition to Prednisolone in Treatment of Warm Antibody Related Autoimmune Hemolytic Anemia. A Randomised Danish Multicenter Trial.
NCT01134432 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-CD20 Antibody Rituximab in Addition to Prednisolone in Treatment of Warm Antibody Related Autoimmune Hemolytic Anemia. A Randomised Danish Multicenter Trial.
- Lead sponsor
- Copenhagen University Hospital at Herlev
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2005
- Completion date
- July 31, 2012
- Enrollment
- 65 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.